Nubentos The API Marketplace For Health SL

Nubentos is a specialized API marketplace focused on healthcare technology, enabling seamless integration of diverse digital health solutions into medical software systems. Founded in 2018, Nubentos operates out of Cadiz, Spain, providing a platform for integrating digital health solutions through APIs. The company has participated in 2 funding deals, with its most recent funding round occurring on January 11, 2022, when it raised EUR 500,000 led by OPS Capital alongside Startupxplore. Nubentos’ founders are not specifically mentioned in the available data.

Nubentos centers its offerings around a comprehensive API marketplace tailored for healthcare technology. It provides a variety of APIs, including services for video consultations, automated ECG interpretation, wellness monitoring, and AI-driven diagnostic support targeting mental health, neurology, and chronic disease management. The company serves diverse clients in the healthcare ecosystem including IT companies, telemedicine providers, insurance firms, pharmacies, and healthcare institutions across Europe, North America, and Latin America. In the most recent fiscal year of 2021, Nubentos reported a revenue of EUR 4,586 and an EBITDA loss of EUR -235,044.

8. The company utilizes a transactional revenue model primarily based on subscriptions and partnerships, allowing clients to integrate specific APIs into their platforms. Key products driving revenue include the 160WorldMeet API for video consultations and the Cardio API for cardiovascular risk assessments, with transactions occurring through both direct B2B agreements and collaborative partnerships. In January 2022, Nubentos raised EUR 500,000 in venture funding to support its growth and consolidate traction gained in the preceding year.

The company plans to continue expanding its product offerings and may target new geographical markets for expansion, enhancing its API services in the healthcare sector. The latest funding will be utilized to support these initiatives, although specific upcoming products or release dates have not been detailed.